Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease

A series of iminosugars bearing two or three alkyl chains ('iminoglycolipids') were designed as ceramide mimics and analogues of N-butyl 1-deoxynojirimycin (N-Bu DNJ, Zavesca®). This orally active iminosugar inhibits the biosynthesis of glucosylceramides, which accumulate pathologically in...

Descripció completa

Dades bibliogràfiques
Autors principals:	Boucheron, C, Desvergnes, V, Compain, P, Martin, O, Lavi, A, Mackeen, M, Wormald, M, Dwek, R, Butters, T
Format:	Journal article
Idioma:	English
Publicat:	2005

Ítems similars

Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
per: Boucheron, C, et al.
Publicat: (2005)

Erratum: Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease (Tetrahedron: Asymmetry (2005) 16 (1747) DOI: 10.1016/j.tetasy.2005.03. 015)
per: Boucheron, C, et al.
Publicat: (2005)

Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
per: Norris-Cervetto, E, et al.
Publicat: (2006)

Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
per: Cécile Baudoin-Dehoux, et al.
Publicat: (2019-01-01)

Iminosugar-based inhibitors of glucosylceramide synthase increase brain glycosphingolipids and survival in a mouse model of Sandhoff disease.
per: Karen M Ashe, et al.
Publicat: (2011-01-01)

Iminosugar inhibitors for treating the lysosomal glycosphingolipidoses
per: Butters, T, et al.
Publicat: (2005)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
per: Norris-Cervetto, E, et al.
Publicat: (2004)

Iminosugars : from synthesis to therapeutic applications /
per: Compain, Philippe, et al.
Publicat: (2007)

Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
per: Gerrard, G, et al.
Publicat: (2009)

Property-based design of a glucosylceramide synthase inhibitor that reduces glucosylceramide in the brain
per: Scott D. Larsen, et al.
Publicat: (2012-02-01)

Quantification of glucosylceramide in plasma of Gaucher disease patients
per: Maria Viviane Gomes Muller, et al.
Publicat: (2010-12-01)

Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease.
per: Mario A Cabrera-Salazar, et al.
Publicat: (2012-01-01)

Iminosugars and methods of treating Arenaviral infections
per: Ramstedt, U, et al.
Publicat: (2010)

Iminosugars and methods of treating viral diseases
per: Ramstedt, U, et al.
Publicat: (2011)

Iminosugars and methods of treating Filoviral diseases
per: Ramstedt, U, et al.
Publicat: (2011)

Iminosugar antivirals: the therapeutic sweet spot
per: Alonzi, D, et al.
Publicat: (2017)

Iminosugars and methods of treating Bunyaviral and Togaviral diseases
per: Ramstedt, U, et al.
Publicat: (2010)

Ubiquitous transgene expression of the glucosylceramide-synthesizing enzyme accelerates glucosylceramide accumulation and storage cells in a Gaucher disease mouse model.
per: Sonya Barnes, et al.
Publicat: (2014-01-01)

Structural and stereochemical studies of potent inhibitors of glucosylceramide synthase and tumor cell growth.
per: A Abe, et al.
Publicat: (1995-03-01)

Glucosylceramide modulates membrane traffic along the endocytic pathway.
per: Sillence, D, et al.
Publicat: (2002)

Iminosugars as therapeutic agents: recent advances and promising trends.
per: Nash, R, et al.
Publicat: (2011)

Glucosylceramide modulates membrane traffic along the endocytic pathway
per: Dan J. Sillence, et al.
Publicat: (2002-11-01)

Fluorescence HPLC Analysis of the in-vivo Activity of Glucosylceramide Synthase
per: Kartik Roy, et al.
Publicat: (2019-06-01)

Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease
per: Kato, A, et al.
Publicat: (2016)

Conformationally constrained fused bicyclic iminosugars: synthetic challenges and opportunities
per: Raphaël Hensienne, et al.
Publicat: (2019-02-01)

Glucosylceramide synthetase inhibitors sensitise B-CLL cells to cytotoxic agents without reversing P-gp functional activity.
per: Gerrard, G, et al.
Publicat: (2004)

Imino sugar therapy for type 1 Gaucher disease.
per: Priestman, D, et al.
Publicat: (2000)

Gaucher disease.
per: Butters, T
Publicat: (2007)

Glucosylceramide Synthase Is Involved in Development of Invariant Natural Killer T Cells
per: Zoran V. Popovic, et al.
Publicat: (2017-07-01)

Glucosylceramide synthase in the fat body controls energy metabolism in Drosophila[S]
per: Ayako Kohyama-Koganeya, et al.
Publicat: (2011-07-01)

ARF6 regulates neuron differentiation through glucosylceramide synthase.
per: Lu Li, et al.
Publicat: (2013-01-01)

Glucosylceramide synthesis and synthase expression protect against ceramide-induced stress
per: Yoshikazu Uchida, et al.
Publicat: (2002-08-01)

Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats
per: T Tokoro, et al.
Publicat: (1987-08-01)

Iminosugar for treatment of tumors
per: Dwek, R, et al.
Publicat: (2008)

Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea virus.
per: Durantel, D, et al.
Publicat: (2001)

Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury
per: Tess V. Dupre, et al.
Publicat: (2017-07-01)

A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy
per: Mali Cosden, et al.
Publicat: (2021-11-01)

Use of iminosugar derivatives to inhibit ion channel activity
per: Zitzmann, N, et al.
Publicat: (2004)

Glucosylceramide flippases contribute to cellular glucosylceramide homeostasis
per: Natsuki Kita, et al.
Publicat: (2024-03-01)

Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.
per: Walden, C, et al.
Publicat: (2007)